Veeva Announces Research Site Clinical Trial Management System
Veeva Systems (NYSE: VEEV) has announced SiteVault CTMS, a new clinical trial management system designed to enhance research site efficiency. The system will be integrated with SiteVault eISF and SiteVault eConsent, enabling comprehensive trial management within a single platform.
The solution features bidirectional data flow integration with sponsors using Veeva's Clinical Platform, aimed at reducing manual processes. Notably, SiteVault CTMS will be free for sites managing up to 20 concurrent active studies, representing over 90% of research sites.
The initial release is planned for August 2025, with live demonstrations scheduled during ACRP 2025 in New Orleans (April 24-27).
Veeva Systems (NYSE: VEEV) ha annunciato SiteVault CTMS, un nuovo sistema di gestione delle sperimentazioni cliniche progettato per migliorare l'efficienza dei siti di ricerca. Il sistema sarà integrato con SiteVault eISF e SiteVault eConsent, consentendo una gestione completa delle sperimentazioni all'interno di un'unica piattaforma.
La soluzione presenta un'integrazione bidirezionale del flusso di dati con gli sponsor che utilizzano la Piattaforma Clinica di Veeva, con l'obiettivo di ridurre i processi manuali. È importante notare che SiteVault CTMS sarà gratuito per i siti che gestiscono fino a 20 studi attivi contemporaneamente, rappresentando oltre il 90% dei siti di ricerca.
Il rilascio iniziale è programmato per agosto 2025, con dimostrazioni dal vivo previste durante l'ACRP 2025 a New Orleans (dal 24 al 27 aprile).
Veeva Systems (NYSE: VEEV) ha anunciado SiteVault CTMS, un nuevo sistema de gestión de ensayos clínicos diseñado para mejorar la eficiencia de los sitios de investigación. El sistema se integrará con SiteVault eISF y SiteVault eConsent, lo que permitirá una gestión integral de ensayos dentro de una única plataforma.
La solución presenta una integración bidireccional del flujo de datos con los patrocinadores que utilizan la Plataforma Clínica de Veeva, con el objetivo de reducir los procesos manuales. Cabe destacar que SiteVault CTMS será gratuito para los sitios que gestionen hasta 20 estudios activos concurrentes, lo que representa más del 90% de los sitios de investigación.
El lanzamiento inicial está previsto para agosto de 2025, con demostraciones en vivo programadas durante el ACRP 2025 en Nueva Orleans (del 24 al 27 de abril).
Veeva Systems (NYSE: VEEV)는 연구 사이트의 효율성을 향상시키기 위해 설계된 새로운 임상 시험 관리 시스템인 SiteVault CTMS를 발표했습니다. 이 시스템은 SiteVault eISF 및 SiteVault eConsent와 통합되어 단일 플랫폼 내에서 포괄적인 시험 관리를 가능하게 합니다.
이 솔루션은 Veeva의 임상 플랫폼을 사용하는 스폰서와의 양방향 데이터 흐름 통합 기능을 제공하여 수동 프로세스를 줄이는 것을 목표로 합니다. 특히, SiteVault CTMS는 동시에 최대 20개의 활성 연구를 관리하는 사이트에 대해 무료로 제공됩니다, 이는 연구 사이트의 90% 이상을 차지합니다.
초기 릴리스는 2025년 8월로 예정되어 있으며, 2025년 ACRP에서 뉴올리언스(4월 24-27일)에서 라이브 데모가 예정되어 있습니다.
Veeva Systems (NYSE: VEEV) a annoncé SiteVault CTMS, un nouveau système de gestion des essais cliniques conçu pour améliorer l'efficacité des sites de recherche. Le système sera intégré avec SiteVault eISF et SiteVault eConsent, permettant ainsi une gestion complète des essais au sein d'une seule plateforme.
La solution dispose d'une intégration bidirectionnelle du flux de données avec les sponsors utilisant la plateforme clinique de Veeva, visant à réduire les processus manuels. Il est à noter que SiteVault CTMS sera gratuit pour les sites gérant jusqu'à 20 études actives simultanément, représentant plus de 90% des sites de recherche.
La première version est prévue pour août 2025, avec des démonstrations en direct programmées lors de l'ACRP 2025 à La Nouvelle-Orléans (du 24 au 27 avril).
Veeva Systems (NYSE: VEEV) hat SiteVault CTMS angekündigt, ein neues System zur Verwaltung klinischer Studien, das darauf abzielt, die Effizienz der Forschungsstandorte zu verbessern. Das System wird mit SiteVault eISF und SiteVault eConsent integriert, um eine umfassende Studienverwaltung auf einer einzigen Plattform zu ermöglichen.
Die Lösung bietet eine bidirektionale Datenflussintegration mit Sponsoren, die die klinische Plattform von Veeva nutzen, mit dem Ziel, manuelle Prozesse zu reduzieren. Besonders hervorzuheben ist, dass SiteVault CTMS für Standorte, die bis zu 20 gleichzeitige aktive Studien verwalten, kostenlos sein wird, was über 90% der Forschungsstandorte ausmacht.
Die erste Veröffentlichung ist für August 2025 geplant, mit Live-Demonstrationen, die während der ACRP 2025 in New Orleans (24.-27. April) stattfinden werden.
- Free offering for majority of research sites (90%) demonstrates market penetration strategy
- Integration with existing Veeva platforms creates comprehensive ecosystem
- Potential for increased market share in clinical trial management space
- Revenue impact may be due to free offering to majority of sites
- Product launch not until August 2025 delays potential market impact
Insights
Veeva's introduction of SiteVault CTMS represents a strategic expansion of their clinical research ecosystem, creating a more comprehensive platform for research sites. By integrating CTMS functionality with existing SiteVault eISF and eConsent products, Veeva now offers sites a unified system for managing all aspects of clinical trials.
The bidirectional data flow between sites and sponsors addresses a significant pain point in clinical trials - the inefficiency of disconnected systems requiring manual data transfer. This integration could meaningfully improve trial execution speed and reduce administrative burden.
From a business perspective, the freemium pricing model (free for sites with up to 20 concurrent studies) serves dual purposes: fulfilling Veeva's Public Benefit mission while strategically driving adoption. This approach could accelerate network effects - as more sites adopt SiteVault CTMS, sponsors using Veeva's Clinical Platform gain greater connectivity benefits, potentially increasing sponsor-side revenue.
This product completes Veeva's site offering and strengthens their competitive moat. By becoming the central operating system for research sites, Veeva creates natural barriers to entry for competitors while enhancing their value proposition for sponsors. The land-and-expand potential is significant as sites using the free version may upgrade when exceeding the threshold or add complementary Veeva products.
The August 2025 launch timeline allows for adequate market preparation and signals Veeva's continued commitment to expanding their clinical trial technology ecosystem.
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors
"We need to work efficiently to help more families enroll their children in studies and get lifesaving treatment," said Theresa Oswald, director of research operations and conduct at Ann & Robert H. Lurie Children's Hospital of
"We are excited to bring Veeva SiteVault CTMS to the industry," said Nick Frenzer, general manager, site solutions at Veeva. "High-quality cloud software and seamless sponsor integration will help sites be more efficient. By making the SiteVault suite free for over
Veeva SiteVault CTMS is planned for initial release in August 2025 and will be free for sites with up to 20 concurrent active studies. Learn more about Veeva SiteVault CTMS and see a live demo during ACRP 2025, April 24-27, in
Additional Information
For more on Veeva's site solutions, visit sites.veeva.com Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-research-site-clinical-trial-management-system-302416520.html
SOURCE Veeva Systems
FAQ
When will Veeva (VEEV) launch its SiteVault CTMS system?
How much will Veeva's (VEEV) SiteVault CTMS cost for research sites?
What integration features does Veeva's (VEEV) new CTMS offer?
What percentage of research sites will qualify for free access to VEEV's SiteVault CTMS?
